Skip to main content
. 2020 Apr 7;63(3):387–394. doi: 10.5468/ogs.2020.63.3.387

Table 2. Surgical characteristics.

Surgical characteristics Bupivacaine No bupivac aine P-value
Surgery performed Robotic hysterectomy 6 18 0.026a)
Laparoscopic hysterectomy 62 40
Robotic adnexa surgery 2 4
Laparoscopic adnexal surgery 25 28
Robotic myomectomy 3 8
Laparoscopic myomectomy 0 1
Robotic TLH + colpopexy 1 1
Laparoscopic TLH + colpopexy 1 0
Pathologic diagnosis Leiomyoma or adenomyosis 61 61 0.642
Endometriosis 3 1
Benign ovarian neoplasm 24 31
Cervical dysplasia 7 4
Cancer 4 2
Other 1 1
Blood loss (mL) Minimal 26 27 0.880
<100 50 49
<200 14 13
<300 4 4
<400 1 4
<500 2 1
≥500 3 2
Hemoglobin decrease 0–0.9 8 5 0.211
1–1.9 33 31
2–2.9 36 35
3–3.9 17 19
4–4.9 2 9
≥5 4 1
Need for additional trocar No additional trocar 92 87 0.003a)
Additional trocar 8 13
Perioperative complication None 99 96 0.359
Bowel injury 0 1
Postoperative infection 1 3
Operation time in minutes 99.40±59.50 109.18±61.20 0.254
Packed RBC transfusion 0.06±0.34 0.03±0.22 0.464
Postoperative analgesic (ampules) 1.80±1.56 1.79±1.54 0.964
Hospital stay after surgery (day) 3.55±0.99 3.51±1.31 0.807
Time of flatus (hours after surgery) 34.49±13.00 32.95±13.00 0.404

Values are presented as number or mean±standard deviation.

TLH, total laparoscopic hysterectomy; RBC, red blood cell.

a)P<0.05.